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Elastase, but not proteinase 3 (PR3), induces proteinuria associated 
with loss of glomerular basement membrane heparan sulphate after 
in vivo renal perfusion in rats
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SUMMARY
Elastase, but not PR3, induces proteinuria associated with loss of glomerular basement membrane 
(GBM) heparan sulphate after in vivo renal perfusion in rats. PR3 and elastase are cationic neutral 
serine proteinases present in the azurophilic granules of polymorphonuclear leucocytes. Release of 
these proteolytic enzymes along the glomerular capillary wall may induce glomerular injury. Here, 
we investigated the effects of PR3 and elastase on the induction of proteinuria and glomerular 
injury after renal perfusion of these enzymes in Brown-Norway rats. Perfusion of active elastase 
induced a dose-dependent proteinuria 24 h after perfusion, while inactivated elastase did not. 
Perfusion of comparable amounts of active PR3 did not induce proteinuria. Light and electron 
microscopy showed no morphological abnormalities in any experimental group. However, 
immunohistology revealed that proteinuria occurring after perfusion of active elastase was 
associated with a strong reduction in intraglomerular expression of the heparan sulphate side 
chain and, to a lesser extent, of the protein core of heparan sulphate proteoglycans (HSPG). In 
vitro, both elastase and PR3 digested HSPG. However, PR3 bound to a lesser extent to HSPG than 
elastase. We conclude that elastase, but not PR3, induces proteinuria after in vivo renal perfusion. 
This differential effect probably relates to different binding to the GBM of those enzymes due to 
differences in their isoelectric points. Degradation of heparan sulfate proteoglycans, leading to the 
disappearance of their side chains that contribute to the poly anionic structure of the GBM, 
appears to be involved in the induction of proteinuria after perfusion of elastase.
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IN T R O D U C TIO N
Polymorphonuclear leucocytes (PMN) contain various pro­
teases in their granules which are released into the extracellular 
space upon activation. It has long been recognized that release 
of these proteases by PMN adherent to the glomerular capillary 
wall may play an important role in the induction of glomerular 
injury, as observed in PMN-dependent glomerulonephritis [I]. 
In this respect, most attention has been focused on the cationic 
neutral serine pro teases elastase and cathepsin G, which are 
present in the azurophilic granules of PMN [2], Evidence for the
Correspondence; C  G. M. Kallenberg, Department o f  Clinical 
Immunology, University Hospital, Oostersingel 59, 9713 BZ  Gronin­
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involvement of these neutral serine proleases in glomerular 
injury has been provided by a number of studies. In vitro, it has 
been shown that elastase and cathepsin G degrade several 
constituents of the glomerular basement membrane (GBM), 
including fibronectin, laminin, and collagen type IV [3 -5). In 
addition, Johnson el al, showed that in vivo renal perfusion of 
//,g quantities of active elastase and cathepsin G results in severe 
proteinuria, while the equally cationic but inactivated enzymes 
do not [6]. Moreover, Schrijver et a i found that Beige mice, 
whose PMN are deficient in elastase and cathepsin G, do not 
develop proteinuria after induction of anli-GBM antibody 
disease [7].
Recently, a novel proteolytic enzyme isolated from human 
PMN was described as FR3. PR3 has been characterized as a
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neutral serine pro tease with a mol. wt of 29 kD and an iso­
electric point of 9*1 [8]. Like cathepsin G and elastase, it is 
present in the azurophilic granules of PMN and released after 
stimulation [9]. Since the discovery that the majority of anti­
neutrophil cytoplasmic antibodies (ANCA) in Wegener’s gran­
ulomatosis (WG) are directed against PR3, the enzyme has 
attracted considerable interest and has been the focus of several 
studies [10,11]. Intratracheal insufflation of PR3 in hamsters 
has been shown to cause emphysema, and, in vitro, PR3 is 
capable of degrading several constituents of the GBM [8,12], 
Furthermore, we recently showed that in renal biopsies from 
patients with WG, PR3 and elastase are localized extracellu- 
larly in renal tissue, suggesting that release of these proteolytic 
enzymes may contribute to glomerular damage as seen in WG
[13]. However, in vivo evidence concerning the role of PR3 in 
glomerular injury is lacking. We therefore studied the effects of 
PR3 on the induction of proteinuria after renal perfusion of /¿g 
quantities of the active enzyme in Brown-Norway rats and 
compared the effects with thoi?e obtained after renal perfusion 
of elastase.
Recently, KlebanofTet a l showed that elastase is capable of 
degrading heparan sulphate proteoglycans (HSPG) of suben- 
dothelial matrix in vitro, suggesting that proteolytic cleavage of 
HSPG may be involved in neutrophil-associated proteinuria
[14]. HSPG consist of a core protein bearing negatively charged 
heparan sulphate glycosaminoglycan chains and are considered 
to be main determinants for the charge-dependent permeability 
of the glomerular capillary wall [15]. In rats, the nephrotic 
syndrome is associated with a loss of GBM HSPG, and 
antibodies to basement membrane HSPG core protein and 
heparan sulphate are nephritogenic [16-18]. Therefore, we 
studied glomerular HSPG core protein and side chain expres­
sion after in vivo renal perfusion of elastase and PR3 in relation 
to the occurrence of proteinuria. We compared the results with 
the in vitro binding and degradation of HSPG by both enzymes.
MATERIALS AND METHODS
Animals
All experiments were performed in conventionally housed, 3- 
month-old Brown-Norway rats. Animals were fed ad libitum 
with standard chow (Hope Farms, Woerden, The Netherlands).
Enzyme activity assay
*  r  *
Enzymatic activity of P R 3 and elastase was quantified by the 
cleavage of the synthetic ester, Boc-alanine-yj-mtrophenyl ester 
(Sigma Chemical Co., St Louis, MO), according to the method 
of Rao el al. [12]. Assays were carried out in a 200-/d final 
volume of 0’05m phosphate buffer pH 7*5 containing 0*5 inM 
substrate and were run and quantified in a 96-we 11 microtitre 
plate (Greiner Inc., Alphen a/d Rijn, The Netherlands) using a 
Titertek multiscan (Titertek Flow Labs, Zwanenburg, The 
Netherlands) for analysis read at 405 nm. One unit of enzy­
matic activity was delined as the amount which cleaved 1 ¿.¿mol 
of substrate in 1 min at 22°C.
Proteolytic assay
Cleavage of casein was assayed according to the methods of 
Twining [19], For each sample, 0*04 % (w/v) resorufin-label led 
casein (Boerhinger Mannheim Biochemica, Mannheim, Ger­
many), 0*2m Tris-HCl pH 7-8, 0*02 m CaCl2, and 1 ¿¿g PR3 or
elastase were incubated in a total volume of 200 /¿I at 37°C for 
16 h. The reaction was stopped by adding 480 /¿I 5% (w/v) 
trichloro acetic acid (TCA). A precipitate was allowed to form 
at 37°C for 10 min, after which the samples were centrifuged at 
13 000 g for 5 min. Next, 400 ¿¿1 of TCA-soluble supernatant 
were neutralized with 600 /il of 0*5 m Tris-HCl pH 8*8. Absor­
bance was read at 574 nm against sample blank. Total hydro­
lysis was determined by incubation with 1 mg pronase 
(Boehringer Mannheim Biochemica) for 16 h at 37°C.
ELISA for leucocy te enzymes
An antigen capture ELISA was used to detect PR3, myeloper­
oxidase (MPO) or elastase, as described [20]. Briefly, microtitre 
plates (Inotech, Breda, The Netherlands) were incubated with 
goat anti-mouse IgG (Jackson, West Grove, PA). After being 
washed, plates were incubated with mouse MoAbs against 
PR3, MPO (MoAb 12.8 and MoAb 4.15, respectively; Central 
Laboratory of the Blood Transfusion Service, Amsterdam, The 
Netherlands) or elastase (Dakopatts, Glostrup, Denmark). 
After another wash, 100 /¿I of different dilutions of the test 
samples in the incubation buffer were added for 1 h at 37°C. 
Bound leucocyte enzymes were then detected with rabbit anti- 
PR3, rabbit anti-MPO and rabbit anti-elastase (both from 
Dakopatts), Bound antibody was detected with alkaline 
phophatase-labelled goat anti-rabbit IgG and y;-nitrophenyl 
phosphate disodium (both from Sigma Chemical Co.) as a 
substrate, Plates were read at 405 nm.
Proteinase 3
PR3 was purified using the methods of Ballieux et al. with 
minor modifications, as described previously [21], Briefly, a- 
granules were isolated from normal human leucocytes by 
sequential nitrogen cavitation and centrifugation on 84% 
Percoll. Pooled a-granules were subjected to two rounds of 
1% Triton X-100 (Kock Light Labs, Ltd, Colnbrook, UK) 
extraction. This a-granule extract was used as the starting 
material for a two-step chromatographic isolation procedure 
for the isolation of PR3, Initially, the a-granule extract was 
applied to a 28 x 1*5 Biorex 70 (BioRad Labs, Richmond, CA) 
column followed by fast performance liquid chromatography 
(FPLC) gel filtration over a 2*6 x 60 cm Superdex 75 column 
(Pharmacia LKB). Fractions were tested for esterolytic activity 
on Boc-alanine-/Miitrophenyl ester and for detection of PR3 
antigen by ELISA. Purity was checked by SDS PAGE, and 
contamination with elastase, cathepsin G or MPO was 
excluded by ELISA. The PR3-positive fractions were pooled, 
dialysed against distilled water, lyophilized and resuspended in 
PBS pH 7-4. Protein concentration was measured according to 
Bradford using bovine serum albumin (BSA) as standard. 
Aliquots of 500/A containing 500 /¿g enzyme were stored at 
-80°C until use.
Elastase
Lyophilized purified human neutrophil elastase was purchased 
from Calbiochem-Behring Co. (La Jolla, CA). This elastase 
was dissolved in PBS pH 7*4 just before use. In some experi­
ments, elastase was irreversibly inactivated by the specific 
elastase inhibitor MSAAPV-chloromethyl ketone (Sigma Che­
mical Co.).
Stimulation o f normal human PM N
For comparative purposes, the amounts of elastase and PR3
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released by activated human PMN were measured. Briefly, 
EDTA blood was drawn from six healthy donors and PMN 
were isolated by centrifugation on a lymphoprep density gra­
dient (Nycorned Pharma AS, Oslo, Norway). Contaminating 
erythrocytes were lysed with ammonium chloride and cell 
concentrations were adjusted to 107/ml in Hanks’ balanced 
salt solution (HBSS; G ibco, Breda, The Netherlands). PMN 
were activated by preincubation with cytochalasin B 5 /ig/ml 
(18015; Serva, Heidelberg, Germany) for 5 min at 37°C fol­
lowed by a 30-min incubation with 10 7 m formyl-methionyl- 
leucyl-phenylalanine (fMLP) (Sigma Chemical Co,) or HBSS 
to estimate spontaneous release. Subsequently, cells were cen­
trifuged at 1000 g for 5 min and supernatants were assayed for 
PR3 and elastase content by antigen capture ELISA, as 
described above, using the enzyme preparation used in the 
perfusion studies as standard. Values were corrected for spon­
taneous release.
Renal perfusion
Perfusion of the left kidney was performed according to the 
methods of Hoyer et cil with minor modifications, as described 
[22] Briefly, rats were anaesthetized with halothane, 0 2, and 
NO2. The aorta and vena cava were then exposed and the 
tributaries ligated. A temporary clamp was placed on the aorta 
above the left renal artery and on the renal vein. A needle was 
inserted in the aorta through a puncture hole and advanced up 
to the level of the left renal artery. A puncture in the left renal 
vein allowed blood and perfusion fluids to escape which were 
collected in cotton wool. Initially, PBS (37WC, pH 7*4) was 
perfused until no visible blood escaped from the punctured 
renal vein. Then, rats were perfused with different doses of 
active elastase (15 /¿g, n =  3; 25 //g, n =  6; and 50 /zg* n =  6) or 
PR3 (50 /¿g, n =  4; 100/ig, n =  3; and 300 /¿g, n =  3) in 0*5 ml 
PBS to establish a dose-response relationship for both 
enzymes. In addition» four rats were perfused with 50/¿g/ 
0-5 ml of MSAAPV chloromethyl ketone-inactivated elastase. 
Control rats were perfused with PBS alone, After 3 min, 
kidneys were cleared with PBS and blood flow was restored. 
Total ischaemia time was always < 11 min. After surgery, rats 
were allowed to recover from anaesthesia for 2 h under a heat 
lamp. Rats were then placed in metabolic cages for 24 h with 
free access to water, and urine was collected.
Urine analysis
Total protein content of the urine samples was measured with 
the quantitative biuret method. Proteinuria was further char­
acterized by 12% SDS PAGE under non-reducing conditions.
microscopy
Twenty-four hours after perfusion rats were killed. Blood was 
d isplaced from both kidneys by perfusion of PBS at 4“C. Tissue 
from both kidneys was processed for light microscopy and 
immunofluorescence. For light microscopy, tissue was fixed in 
2% paraformaldehyde in PBS and embedded in Technovit 8100 
glycolmethacrylate (Kulzer GmbH, Wehrheim, Germany) for 
morphological detail, as described [23]. Sections (2 ¡im) were 
cut on a Reichert Jung Supercut plastic microtome and stained 
with periodic acid-SchifT (PAS) or periodic acid silver metha- 
mine (MZ),
Electron microscopy
Renal tissue was fixed overnight in 2% glutaraldehyde in 0*1 m (Sigma; 125 ng/well) overnight at room temperature. Plates
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phosphate buffer pH 7*4 at 4t’C. Tissue was post-fixed in 1% 
OSO4 for 2 h at 4°C and serially dehydrated in ethanol, then 
embedded in Epon and thin sections (60 nm) were cut. Sections 
were stained with uranyl acetate and lead citrate and examined 
with a Philips EM 201 electron microscope.
L 0 caliz at ion o f P R3 an ¿1 el as l use
Separate experiments were performed to study the localization 
of elastase and PR3 after perfusion by indirect immunofluor­
escence. In these experiments, 50 /¿g of active elastase (n = 2) or 
PR3 (/i =  2) were perfused as described above. Ten minutes 
after reperfusion, rats were killed. For localization of PR3 and 
elastase, renal tissue was snap-frozen in is open thane and 2-/jm 
crysostat sections were cut. Sections were fixed in acetone- 
buffered formalin 9% according to Pryzwansky et al. [24] 
followed by incubation with 10% normal goat serum, PR3 
and elastase were detected by incubating sections with rabbit 
anti-PR3 and rabbit anti-elastase (Dakopatts). Binding was 
visualized with FITC-labelled goat F(ab)2 anti-rabbit IgG 
(Southern Biotechnology Associates, Birmingham, AL).
Immunofluorescence
For indirect immunofluorescence (IIF) renal tissue was snap- 
frozen in isopenthane and 2-/mi sections were cut. Sections 
were Axed in acetone and subsequently incubated with 10% 
normal rabbit or goat serum, depending on the conjugate used. 
Detection of heparan sulphate (HS) side chain was done using 
hybridoma supernatant of mouse anti-rat HS side chain 
(MoAb JM-403) [21], Binding was visualized by FITC-labelled 
goat anti-mouse IgM (Nordic, Tilburg, The Netherlands). To 
detect rat HSPG, we used goat anti serum against human I-IS 
core protein, which has been shown to cross-react with rat 
HSPG [21]. FITC-labelled rabbit anti-goat IgG was used as 
conjugate (Dakopatts). The intraglomerular expression of S- 
luminin, libronectin, and collagen type IV was investigated 
using mouse anti-rat S-laminin, rabbit anti-human libronectin 
(Sigma Chemical Co.), and goat anti-human collagen type IV 
(Southern Biotechnology), which have been shown to cross­
road with rat libronectin and collagen type IV. The following 
conjugates were used: goat anti-mouse IgG FITC (Southern 
Biotechnology), goat F(ab)i anti-rabbit, and rabbit F(ab)2 anti­
goat FfTC (both from Dakopatts). For all slainings, staining 
intensity was scored on a semiquantitative scale (3 + ): 
absent; weak; -h mild; +-K intermediate; H~ ■+• H-, strong, 
using the right non-perfused kidney as reference. In addition, 
kidney sections were double-stained with anti-HS MoAb JM- 
403 and goat anti-HSPG core protein, For this purpose, 
sections were sequentially incubated with: (i) MoAb JM-403; 
(ii) TRITC-labelled goat anti-mouse IgM (Southern Biotech­
nology); (iii) goat anti-HSPG core protein; (iv) FITC-labelled 
rabbit F(ab)2 anti-goat (Dakopatts). The double-staining 
experiments included the following controls; (i) omitting 
MoAb JM-403 or goat anti-HSPG core or both; (ii) incubation 
of MoAb JM-403 or goat anti-HSPG core with the conjugate 
used for the detection of the other antibody in the double 
staining.
In vitro studies
First» the effects of PR3 and elastase on HSPG degradation 
were studied in vitro. For this purpose, micro litre plates (Grei­
ner) were coated with HSPG from the mouse EHS tumour
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were washed with PBS and incubated with elastase, MS A A VP 
chloromethyl ketone-inactivated elastase, PR3 or PMSF-inac- 
tivated PR3 in concentrations ranging from 40 /¿g/ml to 2-4 ng/ 
ml for 1 h at 376C. After washing with PBS-Tween (0-05%), 
plates were incubated with the MoAb directed against HS 
(MoAb JM-403) for l h  at 37UC, followed by peroxidase- 
labelled rabbit anti-mouse (1 h, 37°C). Binding was detected 
using tetramethyl benzidine (TMB; Sigma) as substrate. Plates 
were read at 450 nm, To assess the binding of PR3 and elastase 
to EHS-HSPG, microti tre plates were coated with EHS- 
HSPG and incubated with inactivated elastase and PR3 as 
described above. Then bound elastase and PR3 were detected 
by incubation with rabbit anti-elastase or rabbit anti-PR3 for 
1. h at 37°C. Bound antibody was detected by incubation with 
peroxidase-labelled goat anti-rabbit (Sigma Chemical Co.) for 
lh  at 37°C. Plates were developed and read at 450 nm as 
described above.
Statistical analysis
Results were analysed for statistical significance by Student’s t~ 
test. All results are reported as mean ±  s.e.m. P <0*05 was 
regarded as significant.
R E SU L T S
Characterization o f  PR3 and elastase
On SDS--PAGE the purified PR3 preparation migrated as a 
triplet around 30 kD (Fig. 1). Furthermore, by ELISA, no 
contamination with MPO, cathepsin G or elastase was
Ela PR3
kD
66
45
Vito
31
Table 1. Cleavage o f  Boc-alanme-/?-nitrophenyl ester and casein by PR3
and elastate
Enzyme
Boe-alanine-/j-nitrophenyI 
(niU/mg protein)1“
Casein re so ru (i n -1 a be] led
(% ) t
PR3
Elastase
1086
5140
21 ±3
52 ± 6
* Cleavage of Boc-alanine-/j-nitroplienyl ester is expressed in milli- 
units, where 1 unit i{? defined as the am ount o f  protein which cleaves 
1 /¿mol of substrate in 1 min at 22"C.
t  Proteolytic activity on resorulin-labelled casein is expressed as a 
mean percentage of total hydrolysis by promise. Values represent 
means :h s.e.m, of three separate experiments done in triplicate
detected. As shown in Table 1, enzymatic activity ol 
PR3 was 2*5 or 5 times less than that of elastase as tested on 
resorufin-labelled casein and the synthetic substrate Boc-ala- 
nine-/Miitrophenyl ester, respectively. To estimate the amounts 
of PR3 and elastase which could be released by activated PMN, 
107 isolated PMN from six normal donors were pretreated with 
cytoclmlasin B and stimulated with 10 7 m fMLP. From Table 
2 it can be seen that under these conditions «  3 times more PR3
than elastase was released extracellularly, as quantified by 
ELISA.
Localization o f PR3 and elastase
Infused PR3 and elastase were localized for only a short period 
in the glomeruli. Ten minutes after perfusion no glomeruli 
stained positive for elastase and PR3, as detected by IIF. 
However, strong staining was observed in tubular epithelial 
cells (Fig. 2). Twenty-four hours after perfusion elastase or 
PR3 were detected no more in glomeruli or in tubuli.
Proteinuria after renal perfusion o f elastase and PR3 
Renal perfusion of 50 fig active elastase induced severe protei­
nuria 24 h after perfusion (Table 3). The degree of elastase- 
induced proteinuria was dose-dependent. Proteinuria was not 
observed in rats perfused with 50 fig of inactivated elastase or 
PBS. Furthermore, perfusion of active PR3 did not result in 
proteinuria at all doses studied. Further characterization of
elastase-induced proteinuria by SDS..PAGE revealed that
most urinary proteins were low molecular weight proteins
(Fig. 3).
Table 2. Release o f  PR3 and elasstase from 
normal donor granulocytes afer stimulation 
with 10 7 m fM L P as measured by antigen
capture ELISA
21
D onor PR3 Elastase
1 12
"• *< — “V l*v • »<* •**»•«•»... * wi
4-5
2 10 4-7
3 7*7 3*2
4 14*5 3-3
5 10-3 3*1
6 8-8 2-4
Mean 10*6 ± 2 -2 3-5 d= 0-8
Fig. L M igration o f  PR 3 on a 12% S D S -P A G E  gel. F o r  comparison, 
migration o f  elastase is also shown (Ela), Values represent /.¿gi s.e.m. per 107 PM N.
5 1996 Blackwell Science Ltd, Clinical and Experimental Immunology, 105:321-329
Renal perfusion o f  chistase and PR3 325
; V. .-'¡¡i**'. ‘ÍJv V  * ,s - '.* 'V.y ' ,*•''. ,’ .'•’ .*'-V-: 'rVi *-! ?i7Y:!/;• :7 \ ’-c! • • ^ :^
,:7 7  7  -í '< ' ' V  \Y-' —, 7 . Y ! ' . ; : 'r''. ; 7 :- ' ; ■• 7; > ' —\ ' . ’ J tjÉ *  7..* > i :/ ' - . • 7  ". ' ' i .  , .' . ' ■;" . :. '. v  : .77.' 7.
^ ■ 7 7 : 7 ^ 7 - 7 - - V *  7 7
• } • ‘ s  > «  \ s  * y  <. . * s  '  s  * * • ' ;  * • •  r  • • • •  * é  í S  , • ™  .  *  •• s  > . : • * .  ' . *:  * * r . s - . \ -  ¡ I V  - '  i  *  s  v  I * • * r -* '*• ' > • '  f l B l  • * * '  • • • • « • • : . " .  - v  r >  •* r .  \ s  * * v  * * • '  • v  • • ™  • * • / * •  * :  • * >• *••. .* I / . . ;  / ;  .4vs,> •••/? . \ '  ••• .>.'.• k.v;:. : v.v -.y.-.. i >>.:.•, c  r.. XI : v. .V : T  v/ i :; ^ ; : -r í :: v 'o ; ,v:A i . v V/. ;< i*..  ; : ^  V\v; l-.‘\! -•: .\ i •. 'y V : : 7 :• 7: ; i >:;V: ::V:: ;. ; <: ; : y ^  ;; ; v •
. * .  ;'.. ■ -y f -X X -ú K  X-- *  7 ;; 7 V 7 ' : > 7 .  ' .7 V^rvjrvvi^f:
7 7 ^ : ;  ^ ' - ' , 7  " V  7' ;  . W X X - X X X X - y -  f 7 '7 : * .  :^ - :^ :7 ^ 7 - 7 7 7 ™ 7 7 :^
:-. > .. ^ 1 : \  * '  ‘ » ; 5 • ¿ ‘ ^ ' i ;  P • •.•'.* • • y : : .  •> • ; :.-■:. *  v ;... r. ; i  v.: . :• v: 4  <• / y ;••*•*•; *
É 0 § 0 ^ ^ - y M H  7  v  ■': ■fffv ví:7  ^: -Y • :. ^
W s ^  * • :: ' '*:• **-\-' : •*•*•* * >* >:•:*•*•* •'’ :: ■' >.*! ' • >!• y<
•::^ Ï v^ / '': :: '^7^7 /^ ;:':7:A ''? '''Ï^:'ï :'-,'^ ':'v,- ;':' 7 - : / ' 'V 7 L  ■:•;■■'^ - X :  - - 7 :: 7 a7 ' . 7 ' - v- ^ : - 7 7 7 - \ ¿ l . ; Ä ^ 7 ? * 7 - Ä
7 ' y* S:' r • 7:*¿. f  \  14
\ ’• •• :• }• Y.': ;■:■ rV ':\»: : • ♦■'■■■!s\:> ?'Y:':'.-> =:■ '
:■ ';■'r ■' ■: - - V i ;  « v; ; >:■ ;y: V :''7 ¡;; ' ■>- ' ;>yy ^ 7• • • ► ., , • , • • • ► •. . '  •• ’ . . • •.•/ • « i .............. ......................\ ' ',' ■ ' • s •. ^  •• 1 /
Y ; \  }'•'. : •:■ƒ : \"\  :.. , • * ' . v .  '■'/ O  Y:. ' <■'■_ Y.r . ^  y ;; g
l i l i
^ ' ^ v * í ; ' 7 7 7 :;7 v7 :
::; ; i
,  • Y : . : ' >7  ?Y‘ i .
y^'N y;^ ;■, m
Y:;Y: ■:■.■: Y Y:Y 
yWY'':Y:Y:'::j
: : - ■ ».*:.. ■•■ : 7  ►
' t ' •' • • ■ 7 . ' t : . ty ». ►
: ¡ s /:':V: 
: y. ó '  : > ■ * v  ■ n :Y.
i ► J  i ,
• 7  • '< • ' .  ? • ’
• •• • • - W j / v Ä f ’ *:••■• ••••
'•'7 ; * V > '.ï .  - X X - Í
; V ' > f í ^ . ; ' Y ' Y  
7 Y - ;s: ‘ V :. 1-7'Y;  
• . ; íY ^ ' 7  . ; •  •
■•■■ i 7/r • ' :.: '■ r ►
;.: Y ; ' i  :. '■■
• ■. » .  . -i,-, f . . ,  ► •■ • 
•■y « s* i s
; ; :  I S: . : " :Y : Y V >':
If:;;77yYY;
'Y':Y Y ; :.Y ' v '
M Í : l t 7 S
; Y' 1 Y;. !: ;■ y. v / •: >:: ' . ; YV r :.\ *■ ; ■ : ■.* .V- ; /• r
Y ’ ’ i
■ i - i » ; . - ;
^l-yYY; ■ •s. , .• • «i ’ ’ . •’ • • >• . •. ’ • ’• /  . ’ < •’• ' t '  « •'••'• < /  ' . ' •.t-v /  Y -  i ^ ' *Y: V  t. : 'V y.-V •• • \  /  ' S . \ v r  c-'. y^- ' ; •• :>.: VŸ ' í s : fí^ V V¿ i - !v>
Fig. 2. Renal localization o f  elastase and PR.3 10 min after unilateral 
perfusion of the left kidney as detected by indirect immunofluorescence. 
Localization of elastase (A) and PR3 (B) in tubular epithelial cells, g, 
Glomerulus. (Original mag. x 400.)
Twenty-four hours after perfusion, samples from left and right 
kidneys were taken and studied morphologically by light and 
electron microscopy. By light microscopy, no morphological 
abnormalities such as disruption of the GBM or infiltration of 
PMN and monocytes were seen in any group, ln some elastase-’ 
perfused rats protein absorption droplets were observed in 
tubular epithelial cells. In addition, electron microscopy did 
not reveal glomerular damage in any group. No detachment or 
lysis of glomerular endothelial cells or fusion of epithelial foot 
processes were noted.
Glomerular staining o f  GBM componen ts 
GBM staining of HSPG and HS was studied in kidney 
sections from all groups by IIF using a MoAb direeled 
against HS (MoAb JM-403) and goat antiserum directed 
against the core protein of HSPG (Table 3). In kidney 
sections of PBS-perfused rats strong staining of the GBM 
and Bowman's capsule in a line granular to linear pattern was 
observed with MoAb JM-403 (Fig. 4A). Essentially the same 
staining pattern was obtained with polyclonal antiserum 
against the HSPG core protein (Fig. 4B). Furthermore, the 
pattern and intensity of staining was not different from that in 
right, non-perfused, kidney sections For both antibodies. 
However, after perfusion of 50 y/g active elastase, staining 
for HS with MoAb JM-403 was almost completely absent in 
the glomeruli (Fig. 4E). in some cases staining of Bowman's 
capsule was still positive. In these sections expression of 
H S PG c o re p ro tei n wa s a I so red u ced c om pa red witli sccti ons 
from the right non-perfused kidney and PBS-in fused rats, 
although to a lesser extent than for HS (Fig. 4F). infusion of 
lower doses of active elastase also resulted in a reduction in 
staining for HS along the GBM, but no apparent decrease in 
expression of HSPG core protein was noted (not shown), in 
contrast to the elastase-perfused kidneys, no decrease in 
glomerular HS or HSPG core protein expression was 
observed after infusion of 50 /xg inactivated elastase nor of 
active PR3 at any dose studied (Fig. 4C,D).
In addition to HS and HSPG core protein, glomerular 
expression of S-laminin, fibronectin, and collagen type IV 
was studied by IIF. In kidney sections of PBS-perfu,sed rats a 
linear staining along the GBM together with a prominent 
mesangial staining was obtained with the mouse antibody 
against S-laminin. No differences in staining intensity were 
observed in kidney sections from rats perfused with active 
elastase and all other groups. Furthermore, for fibronectin 
and collagen type IV also no changes in expression were 
observed in all groups (not shown).
Effects o f  PR3 and elastase on HSPG  in vitro 
The in vivo results led us to investigate HSPG degradation by 
elastase and PR3 in vitro .  As shown in Fig. 5a, incubation of 
EHS-HSPG coated to microtitre plates with active PR3 or 
elastase resulted in a dose-dependent loss of HS as detected 
with MoAb JM-403 for both enzymes. The loss of anti-HS 
reactivity could be prevented when the enzymes were inacti­
vated. However, at lower concentrations elastase seemed to be 
more active than PR3 in degrading HSPG. In order to assess 
whether this difference was due to a lower degree of binding of 
PR3 to HSPG, we incubated microtitre plates coated with 
EHS-HSPG with inactivated PR3 and elastase and detected 
the amount of enzyme binding to HSPG. As shown in Fig. 5b, 
PR3 seems to bind less strongly to HSPG than elastase.
DISCUSSION
Activation of PMN adherent to the glomerular capillary wall 
leads to the production of reactive oxygen species and the 
release of their granule constituents, including cationic neutral 
serine proteinases, At the site of degranulation high concentra­
tions of these proteolytic enzymes may be reached which may 
cause glomerular injury by proteolytic cleavage of GBM' con­
stituents and lysis or detachment of glomerular endothelial
©  1996 Blackwell Science Ltd, Clinical and Experimental Immunology* 105:321 -329
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Table 3. and glomerular staini 
protein after renal perfusion of elastase and PR3
an s ï core
Values represent mean ±  s.e.m.
* P <
Perfusate
Concentration 
(/ig/0-5 ml)
Activity
(mil)
Proteinuria
(mg/24 h) HS HSPG
Elastase 50 (6) 257 147-3 ±  35-6* ±
25 (3) 129 38-4 ±4-2* + »■ |- «*|m
15(3) 77 12-6 ±  2-2* M «| I I  ^1 | ^  | i— » » jiw
Elastase inactivated 50 (4) 0 1-5 rfc 0-5 w j r t l  <•*!**< w | « m |w | m  w j m
PR3 300 (4) 326 1 -3 dr 0-2 * > |« I
100 (3 ) 109 1-8 ±0-3 • * ! « «  « * ! « •  w j n p ' « I
50 (3) 54 1-7 ±  0'3 i»ii |»f w i|iiw  r « | *w*| | * i  M>||M
PBS (4) 3-4 rfc 1*9 » j » - «  wt»
was
protein of HS proteoglycan (PG)
and a
, absent; ± , weak; +, mild;
+ + , intermediate; + +  +, strong.
cells. In the present study we evaluated the effects of the human 
PMN-derived neutral serine proteinases elastase and PR3 on 
the induction of proteinuria and the degradation of GBM 
components after in vivo renal perfusion. We showed that 
infusion of ¡ig quantities of active elastase induced a dose- 
dependent proteinuria 24 h after perfusion, while inactivated 
equally cationic elastase did not increase the urinary excretion 
of proteins, demonstrating that the proteolytic activity of 
elastase was responsible for this effect. These results confirm 
the data of Johnson et al., who were the first to show the ability
kD
200
97
66
45
31
21
1 2 3 4 5
Fig. 3. Characterization of 24 h proteinuria by 12% SDS-PAGE after
anes 1 and 4),
(lane 2), 300 /ig PR3 (lane 3) and PBS (lane 5).
of PMN-derived neutral serine proteinases to induce protei­
nuria after renal perfusion [6].
In contrast, we further showed that rats perfused with 
highly purified active PR3 in concentrations up to 300 fig did 
not develop proteinuria. The inability of PR3 to induce protei­
nuria might have been due to perfusion of too low amounts of 
active enzyme in comparison with elastase. As shown, in vitro 
activation of PMN results in the release of «  3 times more PR3 
than elastase. In our perfusion experiments, however, perfusion 
of 300 /ig PR3 (i.e. 20 times more than the lowest dose of 
elastase inducing proteinuria) did not result in proteinuria.
PR3 preparation was comparable to that of elastase at the
So, it seems unlikely that the absence
amounts of active PR3 in 
_, Johnson et al. also men­
tioned in their review
ia [25]. However, i 1  /an ;
with 385 //.g PR3 *1*/*
• injury.
•al serine proteases can also
t \  1 1injure endothelial cells [26]. 
between PR3 and elastase in their effect on cultured endothelial
endothelial cells, while PR3 also induced cytolysis [27]
the severe proteinuria induced after perfusion of acti 
we found no evidence for glomerular
* « ■-> - -1 » I '1* >1
Fig. 4. Glomerular expression of heparan sulphate (HS) (A,C,E) and 
HS proteoglycan (PG) core protein (B,D,F) by indirect immunofluor­
escence double-staining 24 h after perfusion. Strong staining of the 
glomerular basement membrane (GBM) is shown by both antibodies in 
kidney sections of PBS- (A,B, PBS) and PR3- (C,D, proteinase 300 /ig)
;a
(E) was almost completely absent, while staining for HSPG core protein 
was somewhat reduced (F). (Original mag.: A,B, x 250; C F, x 400.)
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al. showed that elastase-induced degradation of subendothelial 
cell matrix HSPG in vitro generates several HSPG fragments of 
different size [14]. They further found that the smaller frag­
ments are preferentially released in the supernatant, while 
larger fragments remain bound to the matrix. This might, 
additionally, explain why in our study HSPG core protein 
still stained strongly positive after elastase perfusion. Several 
other studies have indicated a prominent role for neutrophil 
serine proteinases, especially elastase, in the degradation of 
HSPG [29-31]. In this respect, an interesting study was done by 
Kowanko et al., who showed that neutrophil-mediated degra­
dation of cartilage proteoglycan was primarily induced by 
elastase and cathepsin G, with only a minor role for PR3 [31].
The inability of PR3 to induce proteinuria was somewhat 
surprising, since in vitro studies have shown that PR3 is similar 
to the other PMN-derived neutral serine proteinases elastase
and cathepsin G in exhibiting a broad substrate specificity 
towards GBM
I....I..U.I..LI.I I I I I 11 II J__ I. I I I 111 .1__L. I. I 1,1.1.1. I I I I I I II
0.001 0.01 0.1 1 10 100
Concentration {jxg/ml)
Fig. 5. (a) In vitro degradation of EHS-heparan sulphate proteoglycan 
(HSPG) by elastase and PR3 as demonstrated by ELISA. Anti-HS 
reactivity as detected with MoAb JM-403 is lost after incubation with 
active elastase (A) and PR3 ( • ) .  Elastase seems to be more active than 
PR3. No decrease in anti-HS reactivity is seen after inactivation of PR3
(■) and elastase (A), (b) Binding of inactivated elastase (A) and PR3 
( • )  to EHS-HSPG as measured by ELISA. Elastase seems to bind 
more strongly than PR3.
light and electron microscopy, which observation also corrobo- will then be rapidly filtrated, 
rates the findings of Johnson et al. [6]
[8,12]. Our in vitro data also show 
that PR3, like elastase, is capable of digesting HSPG, i 
to a lesser extent. The differences between elastase and 
their ability to cleave HSPG and inducing proteinuria in vivo 
may be explained by differences in charge between 
enzymes. Studies by Vogt and colleagues have shown that 
glomerular binding of cationic molecules is dependent on 
charge and size o f the molecules [32]. In their studies intrave­
nously injected cationized ovalbumin, a small molecule of 
40 kD, only bound to the GBM when its isoelectric point was 
> 10. PR3 and elastase are both small molecules, but differ 
significantly in their isoelectric point (9-1 for PR3 versus > 11 
for elastase). Therefore, binding of elastase to negi 
charged molecules within the GBM will be much stronger 
than for PR3. This was also shown by our in vitro studies 
comparing the binding of elastase and PR3 with EHS HSPG, 
although the binding characteristics of the detecting antibodies 
may influence the results to some extent. In vivo, the binding of 
PR3 to negatively charged molecules is probably too weak to 
cause any damage. Because of its low molecular weight, PR3
GBM
The absence of cellular injury suggests that degradation of We
glomerular basement components is involved in elastase- dered whether the digestion of HSPG by elastase was selective
induced proteinuria. As mentioned before, elastase is highly for this protein. Earlier studies have shown that the enzymatic
cationic at neutral pH, and binding to the GBM probably removal of HS from the GBM increases the permeability of the
occurs by charge interaction with anionic sites present in the GBM for positively charged, low molecular weight proteins like
GBM. Heparan sulphate, the anionic side chains of HSPG, is albumin and native ferritin [33,34]. Furthermore, i.v. injection
recognized as one of the major determinants of this negative of the anti-HS MoAb used in this study was shown to induce an
charge and is a main determinant of the charge-dependent acute selective proteinuria [18]. Analysis of the elastase-induced
selectivity of the GBM. In this study we showed that protei- proteinuria in this study by SDS PAGE showed the predomi-
nuria occurring after renal perfusion of 50 fig elastase was 
associated with a strong decrease of HS expression as estimated 
by IIP, for HSPG core 
decreased, but to a lesser extent. Infusion of lower amounts 
of elastase also reduced staining for HS, while no apparent 
decrease in staining for HSPG core protein was seen at those 
concentrations. One explanation might be that elastase cleaves 
the HSPG molecule close to the NHa terminus. Recently, it has 
been shown that the HS side chains are attached to the core 
protein very close to the NH 2 terminus [28]. Therefore 
matic removal of (a part of) the NI-L terminus leads to a
of 
et
complete loss of HS side chains, whereas the major 
the core protein remains in the GBM. Moreover, Klebi
nance of lower molecular weight proteins. In addition, by IIP 
we found no decrease or alteration in expression of S-laminin, 
libronectin or collagen type IV compared with control perfused 
rats. These observations may be explained by the preferential 
binding of elastase to the negatively charged HSPG. Once 
bound, elastase will cleave HSPG immediately, resulting in 
loss of the HS side chains. Cleavage products of HSPG, but 
also elastase itself, will then readily be filtrated without digest­
ing other GBM components. In addition, loss of negatively 
charged HSPG leads to proteinuria.
In conclusion, in vivo perfusion of fig quantities of active 
elastase induced a dose-dependent proteinuria, while infusion 
of active PR3 did not. The elastase-induced proteinuria was
((i) 1996 Blackwell Science Ltd, Clinical anil Expérimental Immunology, 105:321 329
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associated with a strong reduction of glomerular HS expression 
and, to a lesser extent, o f HSPG core protein. These studies 
indicate that proteolytic cleavage of HSPG by elastuse may be a 
contributing factor to glomerular injury in PMN-dependent 
glomerulonephritis, and suggest a minor role for PR3.
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